Michael J Schell

13PUBLICATIONS
118CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 26, 2026
External Validation of the ARCAD Nomogram in a Real-World Cohort with Stage 4 Colorectal Cancer.

|Aug 27, 2026
Multidimensional LDCT Imaging Endpoints for a Randomized Pilot Phase II Trial of Curcumin and Omega-3 Fatty Acids for Lung Cancer Chemoprevention: Results of a Randomized Pilot Trial.

|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

|May 04, 2026
Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention.

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Oct 03, 2025
Persistence and clearance of oral human papillomavirus among a multi-national cohort of men.

Brittney L Dickey, Racheal S Dube Mandishora, Bradley Sirak

Pageof 3

Frequent Collaborators

4 joint publications

Anna R Giuliano

3 joint publications

Vernon K Sondak

2 joint publications

Antonio L Amelio

2 joint publications

Christine H Chung